vs
StandardAero, Inc.（SARO）与Surgery Partners, Inc.（SGRY）财务数据对比。点击上方公司名可切换其他公司
StandardAero, Inc.的季度营收约是Surgery Partners, Inc.的1.8倍（$1.6B vs $885.0M），StandardAero, Inc.净利率更高（4.9% vs -1.7%，领先6.6%），StandardAero, Inc.同比增速更快（13.5% vs 2.4%），StandardAero, Inc.自由现金流更多（$307.3M vs $90.6M），过去两年StandardAero, Inc.的营收复合增速更高（13.8% vs 11.1%）
StandardAero Inc.是总部位于美国亚利桑那州斯科茨代尔的专业维护、维修及大修（MRO）服务提供商，深耕相关领域多年，服务覆盖航空等多个行业，可为客户提供高效可靠的定制化运维解决方案。
Surgery Partners, Inc.（NASDAQ代码：SGRY）旗下的United Surgical Partners International（USPI）是美国领先的日间手术护理服务商，总部位于得克萨斯州达拉斯，由唐·斯廷于1998年创立，专注于为患者提供便捷、高效的门诊外科医疗服务，运营多家合规手术中心，覆盖美国多地医疗需求场景。
SARO vs SGRY — 直观对比
营收规模更大
SARO
是对方的1.8倍
$885.0M
营收增速更快
SARO
高出11.1%
2.4%
净利率更高
SARO
高出6.6%
-1.7%
自由现金流更多
SARO
多$216.7M
$90.6M
两年增速更快
SARO
近两年复合增速
11.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $885.0M |
| 净利润 | $78.6M | $-15.0M |
| 毛利率 | 13.8% | — |
| 营业利润率 | 9.3% | 12.5% |
| 净利率 | 4.9% | -1.7% |
| 营收同比 | 13.5% | 2.4% |
| 净利润同比 | 659.6% | 86.2% |
| 每股收益（稀释后） | $0.24 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SAROSGRY
| Q4 25 | $1.6B | $885.0M | ||
| Q3 25 | $1.5B | $821.5M | ||
| Q2 25 | $1.5B | $826.2M | ||
| Q1 25 | $1.4B | $776.0M | ||
| Q4 24 | $1.4B | $864.4M | ||
| Q3 24 | $1.2B | $770.4M | ||
| Q2 24 | $1.3B | $762.1M | ||
| Q1 24 | $1.2B | $717.4M |
净利润SAROSGRY
| Q4 25 | $78.6M | $-15.0M | ||
| Q3 25 | $68.1M | $-22.7M | ||
| Q2 25 | $67.7M | $-2.5M | ||
| Q1 25 | $62.9M | $-37.7M | ||
| Q4 24 | $-14.1M | $-108.5M | ||
| Q3 24 | $16.4M | $-31.7M | ||
| Q2 24 | $5.4M | $-15.5M | ||
| Q1 24 | $3.2M | $-12.4M |
毛利率SAROSGRY
| Q4 25 | 13.8% | — | ||
| Q3 25 | 14.9% | — | ||
| Q2 25 | 15.4% | — | ||
| Q1 25 | 15.2% | — | ||
| Q4 24 | 14.3% | — | ||
| Q3 24 | 15.0% | — | ||
| Q2 24 | 13.7% | — | ||
| Q1 24 | 14.7% | — |
营业利润率SAROSGRY
| Q4 25 | 9.3% | 12.5% | ||
| Q3 25 | 9.2% | 12.9% | ||
| Q2 25 | 8.9% | 13.5% | ||
| Q1 25 | 9.0% | 8.0% | ||
| Q4 24 | 6.7% | 14.7% | ||
| Q3 24 | 7.9% | 7.9% | ||
| Q2 24 | 7.8% | 11.1% | ||
| Q1 24 | 8.5% | 10.6% |
净利率SAROSGRY
| Q4 25 | 4.9% | -1.7% | ||
| Q3 25 | 4.5% | -2.8% | ||
| Q2 25 | 4.4% | -0.3% | ||
| Q1 25 | 4.4% | -4.9% | ||
| Q4 24 | -1.0% | -12.6% | ||
| Q3 24 | 1.3% | -4.1% | ||
| Q2 24 | 0.4% | -2.0% | ||
| Q1 24 | 0.3% | -1.7% |
每股收益（稀释后）SAROSGRY
| Q4 25 | $0.24 | $-0.11 | ||
| Q3 25 | $0.20 | $-0.18 | ||
| Q2 25 | $0.20 | $-0.02 | ||
| Q1 25 | $0.19 | $-0.30 | ||
| Q4 24 | $-0.05 | $-0.86 | ||
| Q3 24 | $0.06 | $-0.25 | ||
| Q2 24 | $0.02 | $-0.12 | ||
| Q1 24 | $0.01 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $239.9M |
| 总债务越低越好 | $2.2B | $3.6B |
| 股东权益账面价值 | $2.7B | $1.7B |
| 总资产 | $6.6B | $8.1B |
| 负债/权益比越低杠杆越低 | 0.83× | 2.10× |
8季度趋势，按日历期对齐
现金及短期投资SAROSGRY
| Q4 25 | — | $239.9M | ||
| Q3 25 | — | $203.4M | ||
| Q2 25 | — | $250.1M | ||
| Q1 25 | — | $229.3M | ||
| Q4 24 | — | $269.5M | ||
| Q3 24 | — | $221.8M | ||
| Q2 24 | — | $213.5M | ||
| Q1 24 | — | $185.2M |
总债务SAROSGRY
| Q4 25 | $2.2B | $3.6B | ||
| Q3 25 | $2.3B | $3.5B | ||
| Q2 25 | $2.3B | $3.5B | ||
| Q1 25 | $2.3B | $3.4B | ||
| Q4 24 | $2.2B | $3.3B | ||
| Q3 24 | $3.4B | $3.1B | ||
| Q2 24 | — | $3.0B | ||
| Q1 24 | — | $2.8B |
股东权益SAROSGRY
| Q4 25 | $2.7B | $1.7B | ||
| Q3 25 | $2.6B | $1.7B | ||
| Q2 25 | $2.5B | $1.7B | ||
| Q1 25 | $2.4B | $1.7B | ||
| Q4 24 | $2.4B | $1.8B | ||
| Q3 24 | $1.2B | $1.9B | ||
| Q2 24 | $1.2B | $2.0B | ||
| Q1 24 | $1.2B | $2.0B |
总资产SAROSGRY
| Q4 25 | $6.6B | $8.1B | ||
| Q3 25 | $6.6B | $7.9B | ||
| Q2 25 | $6.5B | $8.0B | ||
| Q1 25 | $6.5B | $7.9B | ||
| Q4 24 | $6.2B | $7.9B | ||
| Q3 24 | $6.1B | $7.5B | ||
| Q2 24 | — | $7.5B | ||
| Q1 24 | — | $7.0B |
负债/权益比SAROSGRY
| Q4 25 | 0.83× | 2.10× | ||
| Q3 25 | 0.90× | 2.00× | ||
| Q2 25 | 0.92× | 1.98× | ||
| Q1 25 | 0.96× | 1.98× | ||
| Q4 24 | 0.94× | 1.83× | ||
| Q3 24 | 2.94× | 1.63× | ||
| Q2 24 | — | 1.56× | ||
| Q1 24 | — | 1.42× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $323.0M | $103.4M |
| 自由现金流经营现金流 - 资本支出 | $307.3M | $90.6M |
| 自由现金流率自由现金流/营收 | 19.2% | 10.2% |
| 资本支出强度资本支出/营收 | 1.0% | 1.4% |
| 现金转化率经营现金流/净利润 | 4.11× | — |
| 过去12个月自由现金流最近4个季度 | $234.3M | $195.6M |
8季度趋势，按日历期对齐
经营现金流SAROSGRY
| Q4 25 | $323.0M | $103.4M | ||
| Q3 25 | $14.8M | $83.6M | ||
| Q2 25 | $2.9M | $81.3M | ||
| Q1 25 | $-24.0M | $6.0M | ||
| Q4 24 | — | $111.4M | ||
| Q3 24 | $-13.9M | $65.2M | ||
| Q2 24 | — | $82.8M | ||
| Q1 24 | $-83.6M | $40.7M |
自由现金流SAROSGRY
| Q4 25 | $307.3M | $90.6M | ||
| Q3 25 | $-4.7M | $63.8M | ||
| Q2 25 | $-19.0M | $57.9M | ||
| Q1 25 | $-49.3M | $-16.7M | ||
| Q4 24 | — | $89.1M | ||
| Q3 24 | $-39.2M | $45.0M | ||
| Q2 24 | — | $55.9M | ||
| Q1 24 | $-102.0M | $19.7M |
自由现金流率SAROSGRY
| Q4 25 | 19.2% | 10.2% | ||
| Q3 25 | -0.3% | 7.8% | ||
| Q2 25 | -1.2% | 7.0% | ||
| Q1 25 | -3.4% | -2.2% | ||
| Q4 24 | — | 10.3% | ||
| Q3 24 | -3.1% | 5.8% | ||
| Q2 24 | — | 7.3% | ||
| Q1 24 | -8.3% | 2.7% |
资本支出强度SAROSGRY
| Q4 25 | 1.0% | 1.4% | ||
| Q3 25 | 1.3% | 2.4% | ||
| Q2 25 | 1.4% | 2.8% | ||
| Q1 25 | 1.8% | 2.9% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | 2.0% | 2.6% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | 1.5% | 2.9% |
现金转化率SAROSGRY
| Q4 25 | 4.11× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | -0.38× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.84× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -26.22× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SARO
| Commercial Aerospace | $1.0B | 63% |
| Business Aviation | $266.2M | 17% |
| Military And Helicopter | $262.0M | 16% |
| Other | $68.1M | 4% |
SGRY
| Private Insurance | $460.5M | 52% |
| Government Revenue | $368.6M | 42% |
| Other | $19.8M | 2% |
| Self Pay Revenue | $19.6M | 2% |
| Other Patient Service Revenue Sources | $16.5M | 2% |
